Third new TB drug in over half a century must be affordable
Approved as part of a novel shorter treatment regimen, the new drug pretomanid could be a lifesaver for people with XDR-TB, but MSF warns it must be made affordable to make a real difference Doctors Without Borders (MSF) welcomed today’s approval by the US Food and Drug Administration (FDA) of a combination regimen containing a…